{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:55:46Z","timestamp":1791222946288,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Grunenthal and Horizon Pharma"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the association between neutrophil activation and cardiovascular risk in gout patients. We hypothesize that neutrophil activation mediates inflammation and therefore takes part in atherogenesis in gout patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Patient data were collected from 75 consecutive gout patients participating in the Reade gout cohort Amsterdam. Levels of neutrophil extracellular traps (NETs) and neutrophil activation (calprotectin and peroxidase activity) were analysed by ELISA and fluorimetry in plasma and compared with healthy controls. Markers of neutrophil activation were related to clinical markers of cardiovascular risk, including BMI, smoking, blood pressure, lipid profile and 10\u2009year risk of cardiovascular mortality (EU-SCORE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Increased levels of NETs were found in gout patients, although increased levels were not associated with cardiovascular risk. However, markers of neutrophil activation, including peroxidase activity correlated with waist:hip ratio (\u03b2\u2009=\u20090.33, P\u2009&amp;lt;\u20090.001), cholesterol ratio (\u03b2\u2009=\u20090.46, P\u2009&amp;lt;\u20090.005) and triglycerides (\u03b2\u2009=\u20090.60, P\u2009&amp;lt;\u20090.001) as well as the 10\u2009year risk of cardiovascular mortality (\u03b2\u2009=\u20090.44, P\u2009=\u20090.001). Calprotectin levels were elevated in hypertension (P\u2009=\u20090.005) and diabetes (P\u2009=\u20090.02). Finally, gout patients with high levels of both peroxidase and calprotectin (\u2018neutrophil activation signature\u2019) had a markedly elevated cardiovascular risk score (P\u2009=\u20090.001), with 68% of the patients having high cardiovascular risk (odds ratio 2.9, P\u2009=\u20090.03).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We demonstrated elevated levels of neutrophil activation markers, MPO and calprotectin in gout patients as compared with healthy controls. Of note, neutrophil activation markers were associated with several risk factors for cardiovascular disease, including hyperlipidaemia, hypertension and diabetes. Finally, the presence of a neutrophil activation signature was strongly associated with an increased 10\u2009year risk of cardiovascular mortality. Further studies are needed to determine whether gout-specific factors and\/or cardiovascular risk factors contribute to the elevated neutrophil activation observed in these patients.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa712","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T11:41:14Z","timestamp":1602762074000},"page":"2783-2790","source":"Crossref","is-referenced-by-count":19,"title":["A neutrophil signature is strongly associated with increased cardiovascular risk in gout"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1715-9555","authenticated-orcid":false,"given":"Daisy","family":"Vedder","sequence":"first","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center Reade, Amsterdam, The Netherlands"},{"name":"Vrije Universiteit, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Gerritsen","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center Reade, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Nurmohamed","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center Reade, Amsterdam, The Netherlands"},{"name":"Vrije Universiteit, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"},{"name":"Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald F","family":"van Vollenhoven","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center Reade, Amsterdam, The Netherlands"},{"name":"Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lood","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,14]]},"reference":[{"key":"2021061821291639400_keaa712-B1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"2021061821291639400_keaa712-B2","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"key":"2021061821291639400_keaa712-B3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11926-011-0234-2","article-title":"Association between gout and all-cause as well as cardiovascular mortality: a systematic review","volume":"14","author":"Lottmann","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"2021061821291639400_keaa712-B4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10557-016-6706-x","article-title":"Xanthine oxidase induces foam cell formation through LOX-1 and NLRP3 activation","volume":"31","author":"Dai","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"2021061821291639400_keaa712-B5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2147\/TCRM.S5701","article-title":"The role of urate and xanthine oxidase in vascular oxidative stress: future directions","volume":"5","author":"George","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"2021061821291639400_keaa712-B6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13075-016-1012-3","article-title":"Monosodium urate crystals induce oxidative stress in human synoviocytes","volume":"18","author":"Zamudio-Cuevas","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2021061821291639400_keaa712-B7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2021061821291639400_keaa712-B8","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.4049\/jimmunol.1701382","article-title":"Monosodium urate crystals generate nuclease-resistant neutrophil extracellular traps via a distinct molecular pathway","volume":"200","author":"Chatfield","year":"2018","journal-title":"J Immunol"},{"key":"2021061821291639400_keaa712-B9","doi-asserted-by":"crossref","first-page":"e000046","DOI":"10.1136\/rmdopen-2015-000046","article-title":"Why does the gout attack stop? A roadmap for the immune pathogenesis of gout","volume":"1","author":"Schett","year":"2015","journal-title":"RMD Open"},{"key":"2021061821291639400_keaa712-B10","doi-asserted-by":"crossref","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"2021061821291639400_keaa712-B11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"2021061821291639400_keaa712-B12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"key":"2021061821291639400_keaa712-B13","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41467-019-09801-x","article-title":"Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome","volume":"10","author":"Ali","year":"2019","journal-title":"Nat Commun"},{"key":"2021061821291639400_keaa712-B14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/art.39938","article-title":"In vivo role of neutrophil extracellular traps in antiphospholipid antibody-mediated venous thrombosis","volume":"69","author":"Meng","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021061821291639400_keaa712-B15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil extracellular traps in atherosclerosis and atherothrombosis","volume":"120","author":"Doring","year":"2017","journal-title":"Circ Res"},{"key":"2021061821291639400_keaa712-B16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021061821291639400_keaa712-B17"},{"key":"2021061821291639400_keaa712-B18"},{"key":"2021061821291639400_keaa712-B19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/art.41062","article-title":"A neutrophil activation biomarker panel in prognosis and monitoring of patients with rheumatoid arthritis","volume":"72","author":"Bach","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021061821291639400_keaa712-B20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.kint.2018.01.013","article-title":"Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA","volume":"94","author":"Kraaij","year":"2018","journal-title":"Kidney Int"},{"key":"2021061821291639400_keaa712-B21","doi-asserted-by":"crossref","first-page":"38229","DOI":"10.1038\/srep38229","article-title":"Blood-borne phagocytes internalize urate microaggregates and prevent intravascular NETosis by urate crystals","volume":"6","author":"Pieterse","year":"2016","journal-title":"Sci Rep"},{"key":"2021061821291639400_keaa712-B22","article-title":"Detection of uric acid crystals in the vasculature of patients with gout using dual-energy computed tomography","volume":"70(Suppl 10):abstract 2964","author":"Barazani","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2021061821291639400_keaa712-B23","doi-asserted-by":"crossref","first-page":"e0125992","DOI":"10.1371\/journal.pone.0125992","article-title":"Calprotectin and platelet aggregation in patients with stable coronary artery disease","volume":"10","author":"Larsen","year":"2015","journal-title":"PLoS One"},{"key":"2021061821291639400_keaa712-B24","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1002\/art.39656","article-title":"Platelet-derived S100A8\/A9 and cardiovascular disease in systemic lupus erythematosus","volume":"68","author":"Lood","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021061821291639400_keaa712-B25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3389\/fimmu.2017.00928","article-title":"Neutrophil extracellular traps and endothelial dysfunction in atherosclerosis and thrombosis","volume":"8","author":"Qi","year":"2017","journal-title":"Front Immunol"},{"key":"2021061821291639400_keaa712-B26","article-title":"Neutrophil extracellular traps identify patients at risk of increased disease activity and cardiovascular comorbidity in systemic lupus erythematosus","author":"Moore","year":"2019","journal-title":"J Rheumatol"},{"key":"2021061821291639400_keaa712-B27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.41078","article-title":"Neutrophil extracellular traps in tissue and periphery in juvenile dermatomyositis","volume":"72","author":"Duvvuri","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021061821291639400_keaa712-B28","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/rheumatology\/ket263","article-title":"Increased serum levels of S100A8\/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus","volume":"52","author":"Tyden","year":"2013","journal-title":"Rheumatology (Oxford"},{"key":"2021061821291639400_keaa712-B29","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.117.032636","article-title":"Cholesterol efflux pathways suppress inflammasome activation, NETosis, and atherogenesis","volume":"138","author":"Westerterp","year":"2018","journal-title":"Circulation"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2783\/38694990\/keaa712.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2783\/38694990\/keaa712.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T20:46:34Z","timestamp":1696884394000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/6\/2783\/5981976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,14]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,11,14]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa712","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2020,11,14]]}}}